The Arf/p53 pathway in cancer and aging

108Citations
Citations of this article
147Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Arf and p53 are regarded among the most relevant tumor suppressors based on their ubiquitous and frequent inactivation in human cancer. The Arf/p53 pathway protects cells against several types of damage and this is the basis of its tumor suppressor activity. Interestingly, aging is a process associated with the accumulation of damage derived from chronic stresses of small magnitude. In agreement with its damage protection role, it has been recently described that the Arf/p53 pathway not only protects mammalian organisms from cancer but also from aging. However, there is also evidence that p53, under certain circumstances, such as when constitutively active, can induce aging. We discuss here the current evidence linking the Arf/p53 pathway to the process of aging and present a unified model. ©2008 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Matheu, A., Maraver, A., & Serrano, M. (2008, August 1). The Arf/p53 pathway in cancer and aging. Cancer Research. https://doi.org/10.1158/0008-5472.CAN-07-6851

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free